NK Cell-Based Glioblastoma Immunotherapy

Glioblastoma (GB) is the most aggressive and most common malignant primary brain tumor diagnosed in adults. GB shows a poor prognosis and, unfortunately, current therapies are unable to improve its clinical outcome, imposing the need for innovative therapeutic approaches. The main reason for the poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Golán, Irene, Rodríguez de la Fuente, Laura, Costoya, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315402/
https://www.ncbi.nlm.nih.gov/pubmed/30567306
http://dx.doi.org/10.3390/cancers10120522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315402/
https://www.ncbi.nlm.nih.gov/pubmed/30567306
http://dx.doi.org/10.3390/cancers10120522

Ejemplares similares